ARCHIVES

Cancer Groups In Campaign To Draft Pazdur For FDA.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Research teams link response to Iressa to mutations in EGF receptor.

April 30, 2004

Zubrod To Retire as Miami Director; Baker Succeeds Brennan As Director Of Detroit Center

January 29, 1988

Human Genome Project publishes its final product.

October 22, 2004

FDA approves Irinotecan, Days After ODAC Meeting

June 21, 1996

ACS Medals Of Honor To Bonadonna, Hsu, Louis Sullivan

December 13, 1991

ODAC Meeting: Further Restrictions Likely On ESA Use; Changes Advocated by ODAC May Cut Market By 40-50 Percent.

March 21, 2008